U.S. Continuous Positive Airway Pressure Devices Market
Description
U.S. Continuous Positive Airway Pressure Devices Market Summary
The U.S. continuous positive airway pressure devices market size was estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.07 billion by 2033, growing at a CAGR of 5.50% from 2026 to 2033. This is attributed to the rising prevalence of sleep apnea and respiratory disorders, technological advancements in continuous positive airway pressure devices (CPAP) devices, growing awareness and diagnosis of sleep apnea, and favorable reimbursement policies.
For instance, Medicare covers a 3-month trial of CPAP devices and accessories for individuals diagnosed with obstructive sleep apnea. The incidence of sleep apnea and other respiratory disorders is on the rise in the U.S., primarily due to factors such as obesity, sedentary lifestyles, and an aging population. According to the Centers for Disease Control and Prevention (CDC) estimates published in May 2024, between August 2021 and August 2023, the obesity rate among adults was 40.3%, with no notable differences between women & men. Obesity was higher in adults aged 41-60 compared to those aged 20-39 and those 60 and older. This growing obesity rate contributes significantly to the increasing prevalence of sleep apnea, thereby driving the demand for CPAP devices.
Moreover, continuous innovations in CPAP technology have significantly enhanced patient comfort and therapy effectiveness. Modern CPAP machines feature quieter motors, compact designs, integrated humidification systems, and advanced data-tracking capabilities. These improvements address common patient concerns, such as noise and discomfort, thereby increasing therapy adherence rates.
Government health agencies and non-profit organizations frequently conduct public awareness initiatives to inform individuals about sleep apnea and treatment needs. For instance, in May 2024, the CDC in the U.S. incorporated sleep apnea into its broader public health campaigns on sleep hygiene and the management of chronic diseases.
The rental model plays a significant role in shaping the adoption of continuous positive airway pressure devices in the U.S., as well as pricing and revenue dynamics. CPAP devices are commonly provided to patients on a rent-to-own basis, typically over a 10 to 13-month period, driven largely by insurance reimbursement policies, including those of Medicare and private payers. In addition, this model reduces upfront costs for patients, enhances therapy initiation rates, and enables payers to verify compliance before full ownership, thereby facilitating broader market penetration.
However, it also slows immediate device sales revenue recognition for manufacturers, shifts purchasing power toward DME providers, and increases the importance of long-term patient adherence, remote monitoring, and replacement cycles (such as masks, tubing, and filters). CPAP rentals contribute to steady, recurring demand, greater price sensitivity, and stronger emphasis on connected devices and service-based differentiation in the U.S. continuous positive airway pressure (CPAP) devices industry.
U.S. Continuous Positive Airway Pressure Devices Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2026 to 2033. For this study, Grand View Research has segmented the U.S. continuous positive airway pressure devices market report based on connectivity and end use.
The U.S. continuous positive airway pressure devices market size was estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.07 billion by 2033, growing at a CAGR of 5.50% from 2026 to 2033. This is attributed to the rising prevalence of sleep apnea and respiratory disorders, technological advancements in continuous positive airway pressure devices (CPAP) devices, growing awareness and diagnosis of sleep apnea, and favorable reimbursement policies.
For instance, Medicare covers a 3-month trial of CPAP devices and accessories for individuals diagnosed with obstructive sleep apnea. The incidence of sleep apnea and other respiratory disorders is on the rise in the U.S., primarily due to factors such as obesity, sedentary lifestyles, and an aging population. According to the Centers for Disease Control and Prevention (CDC) estimates published in May 2024, between August 2021 and August 2023, the obesity rate among adults was 40.3%, with no notable differences between women & men. Obesity was higher in adults aged 41-60 compared to those aged 20-39 and those 60 and older. This growing obesity rate contributes significantly to the increasing prevalence of sleep apnea, thereby driving the demand for CPAP devices.
Moreover, continuous innovations in CPAP technology have significantly enhanced patient comfort and therapy effectiveness. Modern CPAP machines feature quieter motors, compact designs, integrated humidification systems, and advanced data-tracking capabilities. These improvements address common patient concerns, such as noise and discomfort, thereby increasing therapy adherence rates.
Government health agencies and non-profit organizations frequently conduct public awareness initiatives to inform individuals about sleep apnea and treatment needs. For instance, in May 2024, the CDC in the U.S. incorporated sleep apnea into its broader public health campaigns on sleep hygiene and the management of chronic diseases.
The rental model plays a significant role in shaping the adoption of continuous positive airway pressure devices in the U.S., as well as pricing and revenue dynamics. CPAP devices are commonly provided to patients on a rent-to-own basis, typically over a 10 to 13-month period, driven largely by insurance reimbursement policies, including those of Medicare and private payers. In addition, this model reduces upfront costs for patients, enhances therapy initiation rates, and enables payers to verify compliance before full ownership, thereby facilitating broader market penetration.
However, it also slows immediate device sales revenue recognition for manufacturers, shifts purchasing power toward DME providers, and increases the importance of long-term patient adherence, remote monitoring, and replacement cycles (such as masks, tubing, and filters). CPAP rentals contribute to steady, recurring demand, greater price sensitivity, and stronger emphasis on connected devices and service-based differentiation in the U.S. continuous positive airway pressure (CPAP) devices industry.
U.S. Continuous Positive Airway Pressure Devices Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2026 to 2033. For this study, Grand View Research has segmented the U.S. continuous positive airway pressure devices market report based on connectivity and end use.
- Connectivity Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
- Connected
- Bluetooth-Connected CPAP
- Wi-Fi & Cellular Connected CPAP
- Hybrid-Connected
- Non-Connected
- End Use Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
- Home Care Settings
- Hospitals & Clinics
- Others (Long-Term Care Facilities, etc.)
Table of Contents
120 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR’s Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Product Outlook
- 2.3. Distribution Channel Outlook
- 2.4. Regional Outlook
- Chapter 3. Vegan Food Market Variables, Trends & Scope
- 3.1. Market Introduction
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Sales/Retail Channel Analysis
- 3.3.2. Profit Margin Analysis
- 3.4. Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.2. Market Restraint Analysis
- 3.4.3. Industry Challenges
- 3.4.4. Industry Opportunities
- 3.5. Business Environment Analysis
- 3.5.1. Industry Analysis - Porter’s
- 3.5.1.1. Supplier Power
- 3.5.1.2. Buyer Power
- 3.5.1.3. Substitution Threat
- 3.5.1.4. Threat from New Entrant
- 3.5.1.5. Competitive Rivalry
- 3.6. Market Entry Strategies
- Chapter 4. Consumer Behavior Analysis
- 4.1. Demographic Analysis
- 4.2. Consumer Trends and Preferences
- 4.3. Factors Affecting Buying Decision
- 4.4. Observations & Recommendations
- Chapter 5. Vegan Food Market: Product Estimates & Trend Analysis
- 5.1. Vegan Food Market, By Product: Key Takeaways
- 5.2. Product Movement Analysis & Market Share, 2025 & 2033
- 5.3. Market Estimates & Forecasts, by Product, 2021 - 2033 (USD Million)
- 5.3.1. Meat & Seafood
- 5.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.2. Creamer
- 5.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.3. Ice cream and frozen novelties
- 5.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.4. Yogurt
- 5.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.5. Cheese
- 5.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.6. Butter
- 5.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.7. Meals
- 5.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.8. Protein liquids & powders
- 5.3.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.9. Protein bars
- 5.3.9.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.10. Others
- 5.3.10.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 6. Vegan Food Market: Distribution Channel Estimates & Trend Analysis
- 6.1. Vegan Food Market, By Distribution Channel: Key Takeaways
- 6.2. Distribution Channel Movement Analysis & Market Share, 2025 & 2033
- 6.3. Market Estimates & Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
- 6.3.1. Offline
- 6.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.2. Online
- 6.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 7. Vegan Food Market: Regional Estimates & Trend Analysis
- 7.1. Vegan Food Market: Regional Outlook
- 7.2. Regional Movement Analysis & Market Share, 2025 & 2033
- 7.3. Market Estimates & Forecasts, by Region & Country, 2021 - 2033 (USD Million)
- 7.3.1. North America
- 7.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.1.2. The U.S.
- 7.3.1.2.1. Key country dynamics
- 7.3.1.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.1.3. Canada
- 7.3.1.3.1. Key country dynamics
- 7.3.1.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.1.4. Mexico
- 7.3.1.4.1. Key country dynamics
- 7.3.1.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.2. Europe
- 7.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.2.2. The UK
- 7.3.2.2.1. Key country dynamics
- 7.3.2.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.2.3. Germany
- 7.3.2.3.1. Key country dynamics
- 7.3.2.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.2.4. France
- 7.3.2.4.1. Key country dynamics
- 7.3.2.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.2.5. Italy
- 7.3.2.5.1. Key country dynamics
- 7.3.2.5.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.2.6. Spain
- 7.3.2.6.1. Key country dynamics
- 7.3.2.6.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.3. Asia Pacific
- 7.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.3.2. China
- 7.3.3.2.1. Key country dynamics
- 7.3.3.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.3.3. India
- 7.3.3.3.1. Key country dynamics
- 7.3.3.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.3.4. Japan
- 7.3.3.4.1. Key country dynamics
- 7.3.3.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.3.5. South Korea
- 7.3.3.5.1. Key country dynamics
- 7.3.3.5.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.3.6. Australia & New Zealand
- 7.3.3.6.1. Key country dynamics
- 7.3.3.6.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.4. Central & South America
- 7.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.4.2. Brazil
- 7.3.4.2.1. Key country dynamics
- 7.3.4.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.5. Middle East & Africa
- 7.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.5.2. South Africa
- 7.3.5.2.1. Key country dynamics
- 7.3.5.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Analysis
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Participant’s Overview
- 8.4. Financial Performance
- 8.5. Product Benchmarking
- 8.6. Company/Brand Market Share Analysis, 2025 (%)
- 8.7. Company Heat Map Analysis
- 8.8. Strategy Mapping
- 8.9. Company Profiles
- 8.9.1. Danone S.A.
- 8.9.1.1. Company Overview
- 8.9.1.2. Financial Performance
- 8.9.1.3. Product Benchmarking
- 8.9.1.4. Strategic Initiatives
- 8.9.2. Daiya Foods, Inc.
- 8.9.2.1. Company Overview
- 8.9.2.2. Financial Performance
- 8.9.2.3. Product Benchmarking
- 8.9.2.4. Strategic Initiatives
- 8.9.3. Beyond Meat
- 8.9.3.1. Company Overview
- 8.9.3.2. Financial Performance
- 8.9.3.3. Product Benchmarking
- 8.9.3.4. Strategic Initiatives
- 8.9.4. Tofutti Brands Inc.
- 8.9.4.1. Company Overview
- 8.9.4.2. Financial Performance
- 8.9.4.3. Product Benchmarking
- 8.9.4.4. Strategic Initiatives
- 8.9.5. Plamil Foods Ltd
- 8.9.5.1. Company Overview
- 8.9.5.2. Financial Performance
- 8.9.5.3. Product Benchmarking
- 8.9.5.4. Strategic Initiatives
- 8.9.6. VBites Foods Limited
- 8.9.6.1. Company Overview
- 8.9.6.2. Financial Performance
- 8.9.6.3. Product Benchmarking
- 8.9.6.4. Strategic Initiatives
- 8.9.7. Eden Foods Inc.
- 8.9.7.1. Company Overview
- 8.9.7.2. Financial Performance
- 8.9.7.3. Product Benchmarking
- 8.9.7.4. Strategic Initiatives
- 8.9.8. Amy’s Kitchen
- 8.9.8.1. Company Overview
- 8.9.8.2. Financial Performance
- 8.9.8.3. Product Benchmarking
- 8.9.8.4. Strategic Initiatives
- 8.9.9. VITASOY International Holdings Limited
- 8.9.9.1. Company Overview
- 8.9.9.2. Financial Performance
- 8.9.9.3. Product Benchmarking
- 8.9.9.4. Strategic Initiatives
- 8.9.10. SunOpta
- 8.9.10.1. Company Overview
- 8.9.10.2. Financial Performance
- 8.9.10.3. Product Benchmarking
- 8.9.10.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



